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The International Space Station (ISS) is a closed environment wi~h rotations of crew and equipment each 
introducing their own microbial flora making it necessary to monitor the air, surfaces, and water for 
microbial contamination. Current microbial monitoring includes labor and time intensive methods to 
enumerate total bacterial and fungal cells with limited characterization during in-flight testing. Although 
this culture-based method has been sufficient for monitoring the ISS, future long duration missions will 
need to perform more comprehensive characterization in-flight, since sample return and ground 
characterization may not be available. A workshop was held in 2011 at the Johnson Space Center to 
discuss alternative methodologies and technologies suitable for microbial monitoring for these long-
term exploration missions where molecular-based methodologies, such as polymerase chain reaction 
(PCR), were recommended. In response, a multi-center (Marshall Space Flight Center, Johnson Space 
Center, Jet Propulsion Laboratory, and Kennedy Space Center) collaborative research effort was initiated 
to explore novel commercial-off-the-shelf hardware options for spaceflight environmental monitoring. 
The goal was to evaluate quantitative/semi-quantitative PCR approaches to space applications for low 
cost in-flight rapid identification of microorganisms affecting crew safety. The initial phase of this 
project identified commercially available platforms that could be minimally modified to perform 
nominally in microgravity followed by proof-of-concept testing on the highest qualifying candidates with 
a universally available test organism, Salmonella enterica. The platforms evaluated during proof-of-
concept testing included the iCubate 2.0® (iCubate, Huntsville, AL), RAZOR EX® (BioFire Diagnostics; Salt 
Lake City, Utah) and SmartCycler® (Cepheid; Sunnyvale, CA) . The analysis identified two potential 
technologies (iCubate 2.0 and RAZOR EX) that were able to perform sample-to-answer testing with cell 
sample concentrations between SO to 400 cells. In addition, the commercial systems were evaluated for 
initial flight safety and readiness, sample concentration needs were reviewed, and a competitive 
procurement of commercially available platforms was initiated. 
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